Get in Touch
Get in Touch

NEWS

NEWS 2024

NEWS

NEWS 2024

News Highlights

Check this page for recent news from Appili Therapeutics.
Members of the media can contact us
General inquiries, contact us
October 17, 2024

Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024

Read More
October 10, 2024

Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders

Read More
September 17, 2024

Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

Read More
August 21, 2024

Appili Therapeutics Announces Third Amendment to Arrangement Agreement and Provides Updated on Transaction with Aditxt

Read More
August 13, 2024

Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2025

Read More
July 18, 2024

Appili Therapeutics Announces Second Amendment to Arrangement Agreement

Read More
July 2, 2024

Appili Therapeutics Announces Amendment to Arrangement Agreement and Increase to Bridge Loan

Read More
June 25, 2024

Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results

Read More
April 26, 2024

Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.

Read More
April 2, 2024

Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.

Read More
March 12, 2024

Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks

Read More
February 13, 2024

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024

Read More

PIPELINE

STRATEGY

ABOUT US

APPILI THERAPEUTICS

Phone

  • Copyright 2022 © Appili Therapeutics